BiotechTube
Home/CasInvent Pharma/Vojtěch Helikar
VH

Vojtěch Helikar

CFO / COO

CasInvent Pharma

Therapeutic Areas

Oncology

CasInvent Pharma Pipeline

DrugIndicationPhase
CK1 Inhibitor ProgramResistant Acute Myeloid Leukemia (AML), Solid Tumors (PDAC, TNBC, Melanoma, Prostate Cancer)Preclinical

Leadership Team at CasInvent Pharma

AS
Alexander Scheer
CEO / CSO
KP
Kamil Paruch
Head of Chemistry
TR
Tomasz Radaszkiewicz
Head of Biology
View full CasInvent Pharma profile